{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:45:29Z","timestamp":1791276329311,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T00:00:00Z","timestamp":1229385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Deficiency of ADAMTS13 (<jats:styled-content>a<\/jats:styled-content><jats:styled-content>d<\/jats:styled-content>isintegrin\u2010like <jats:styled-content>a<\/jats:styled-content>nd <jats:styled-content>m<\/jats:styled-content>etalloproteinase with <jats:styled-content>t<\/jats:styled-content>hrombo<jats:styled-content>s<\/jats:styled-content>pondin type\u20101 motifs <jats:styled-content>13<\/jats:styled-content>) results in an increase in unusually large von Willebrand factor multimer (UL\u2010VWFM) of the plasma and finally causes microcirculatory disturbance. Our previous study demonstrated that the imbalance of increased UL\u2010VWFM over decreased ADAMTS13 activity may contribute to the development of multiorgan failure in patients with alcoholic hepatitis (AH). The aim of this study was to explore the potential mechanism to reduce the activity of plasma ADAMTS13.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Plasma cytokine levels including interleukin (IL)\u20106, IL\u20108, and tumor necrosis factor\u2010\u03b1 (TNF\u2010\u03b1), plasma endotoxin concentration, and the plasma inhibitor against ADAMTS13 were determined together with ADAMTS13 activity, VWF antigen (VWF:Ag), and UL\u2010VWFM in 24 patients with AH and 5 patients with severe alcoholic hepatitis (SAH).<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The concentrations of IL\u20106, IL\u20108, and TNF\u2010\u03b1 on admission were significantly higher in patients with SAH than in those with AH and controls. The ADAMTS13 activity concomitantly decreased, and the VWF:Ag progressively elevated with increasing concentrations of these cytokines from normal range to over 100\u2003pg\/ml. Plasma endotoxin concentration was markedly higher in patients with SAH (mean 52.3\u2003pg\/ml) and AH (21.7\u2003pg\/ml) than in controls (7.9\u2003pg\/ml). The endotoxin concentration inversely correlated with ADAMTS13 activity and was higher in patients with UL\u2010VWFM than those without. The inhibitor was detected in 4 patients with SAH (0.9 to 2.1\u2003BU\/ml) and 6 patients with AH (0.5 to 1.6\u2003BU\/ml). Patients with the inhibitor showed lower functional liver capacity, higher endotoxin concentration, and marked inflammatory signs than those without. At the recovery stage, the ADAMTS13 activity increased to normal range, the VWF:Ag decreased, and the UL\u2010VWFM disappeared with the decrease in the concentrations of cytokines and endotoxin, and the disappearance of the inhibitor.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Decreased ADAMTS13 activity and increased VWF:Ag could be induced not only by pro\u2010inflammatory cytokinemia, but also by its inhibitor, both of which may be closely related to enhanced endotoxemia in patients with AH and SAH.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2008.00850.x","type":"journal-article","created":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T23:39:14Z","timestamp":1229643554000},"source":"Crossref","is-referenced-by-count":29,"title":["Potential Role of Enhanced Cytokinemia and Plasma Inhibitor on the Decreased Activity of Plasma ADAMTS13 in Patients With Alcoholic Hepatitis: Relationship to Endotoxemia"],"prefix":"10.1111","volume":"34","author":[{"given":"Masatoshi","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Ishizashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Takimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,13]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0107"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11677"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-9-685"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04531.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02981975"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90933-3"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392202"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.9.3097"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.03217.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/alcalc\/28.Supplement_1B.97","article-title":"Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis","volume":"1","author":"Ishii K","year":"1993","journal-title":"Alcohol Alcohol"},{"key":"e_1_2_7_12_1","first-page":"869","article-title":"A more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper CK","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/08880010290097288"},{"key":"e_1_2_7_14_1","first-page":"ECR34","article-title":"Thrombotic thrombocytopenic purpura associated with pegylated\u2010interferon alpha\u20102a by an ADAMTS13 inhibitor in a patient with chronic hepatitis C","volume":"91","author":"Kitano K","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20733"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.172277399"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/35097008"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080207"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90401-8"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2730"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2003.10.009"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2006.00283.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020528"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.8.1182"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00100.x"},{"key":"e_1_2_7_26_1","first-page":"21","article-title":"Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease","volume":"24","author":"Moschcowitz E","year":"1924","journal-title":"Proc NY Pathol Sac"},{"key":"e_1_2_7_27_1","first-page":"321","article-title":"Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: Comparison with conventional procedures and clinical applications","volume":"104","author":"Obayashi T","year":"1984","journal-title":"J Lab Clin Med"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(85)90273-6"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1087"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703544"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1397"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-08-0467"},{"key":"e_1_2_7_33_1","first-page":"S41","article-title":"von Willebrand factor","volume":"100","author":"Ruggeri ZM","year":"1997","journal-title":"J Clin Invest"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a003009"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.2957\/kanzo.34.888"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1616068"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196603032740901"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392203"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-01-0006"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.alc.0000192326.08931.cb"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0152"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.08.030"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100515200"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2008.00850.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2008.00850.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:32:45Z","timestamp":1694629965000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2008.00850.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,13]]},"references-count":42,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1530-0277.2008.00850.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2008.00850.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,13]]}}}